The Acute Lung Injury Market Size and Growth impelled by increasing prevalence of respiratory diseases and rising geriatric population; In 2021, the mechanical ventilation segment accounted for the largest market share.

New York, Sept. 28, 2021 (GLOBE NEWSWIRE) -- Acute Lung Injury Market: Key Insights
According to our new research study on "Acute Lung Injury Market to 2028 – Global Analysis and Forecast – by Therapy, End User, and Geography," the Acute Lung Injury Market Size is projected to reach US$ 741.98 million by 2028 from US$ 539.61 million in 2021; it is expected to register a CAGR of 4.7% during 2021–2028.

Acute Lung Injury Market: Competition Landscape and Key Developments
GlaxoSmithKline plc.; Stemedica Cell Technologies, Inc; Histocell; APEPTICO Forschung und Entwicklung GmbH; Windtree Therapeutics, Inc.; ReAlta Life Sciences, Inc.; Apeiron Biologics AG, Qx Therapeutics, Inc., Angion, and Asklepion Pharmaceuticals, LLC. are among the major players operating in the market. Currently, various molecules of these companies are under development in Phase II, Phase I, and Preclinical. Leading market players are focusing on the launch of new products, expansion, and diversification of market presence and acquisition of new customer base, thereby tapping prevailing business opportunities.

Get Exclusive Sample Pages of Acute Lung Injury Market Size - COVID-19 Impact and Global Analysis with Strategic Insights at https://www.theinsightpartners.com/sample/TIPRE00015798/

In 2020, North America dominated the global acute lung injury market. The market's growth is majorly defined by the increasing investments and initiatives by market players and governments. The acute lung injury market players are actively involved in business development activities such as product launches and partnerships. For instance, in March 2021, Qx Therapeutics Inc. announced that the US Food and Drug Administration (FDA) cleared investigational new drug application (IND) to investigate its lead drug product, QXT-101, for a Phase 2 clinical trial for its safety and efficacy in hospitalized patients with severe or critical COVID-19. QXT-101 is a first-in-class treatment for patients who suffer from acute lung injury (ALI). Thus, continuous efforts and investments by the market players by uplifting the production and sales of their products in the domestic and international markets to address the rising demands are driving the acute lung injury market.

The COVID-19 pandemic has disrupted the socioeconomic conditions of various countries across the world. The high number of COVID cases has negatively impacted the country's and region's economy, and there has been a decline in overall business activities and growth of various industries operating in the region.

However, acute lung injury market players are initiating clinical trials to develop drugs to treat acute lung injury. For instance, Chimerix, a biopharmaceutical company, initiated a Phase II/III clinical trial in June 2020 to evaluate the safety and efficacy of Dociparstat sodium (DSTAT) in patients with acute lung injury (ALI) due to COVID-19. Furthermore, Altasciences is pleased to support ReAlta Life Sciences by conducting a Phase I trial to evaluate RLS-0071 for acute lung injury (ALI) as a result of viral infections such as COVID-19, respiratory syncytial virus (RSV), and influenza. COVID-19-related issues have propelled the acute lung injury market growth in the region.

Download Sample PDF Brochure of Acute Lung Injury Market Size and Growth Research Report at https://www.theinsightpartners.com/sample/TIPRE00015798/

The high prevalence of respiratory conditions is associated with the decrease in the size of the upper airway lumen in the aging population. Lung disorders are among the most common medical conditions across the world. According to the Centers for Disease Control and Prevention (CDC), lung diseases such as chronic obstructive pulmonary disease (COPD) and acute lung injury (ALI) are the third leading cause of death in the US. People worldwide suffer from various sorts of respiratory diseases. Smoking, infections, and genetic factors are among the common factors responsible for respiratory disorders. Medical conditions such as COPD, asthma, chronic bronchitis, cystic fibrosis, and lung cancer are significant public health burdens.

Moreover, the CDC, the US Food and Drug Administration (FDA), state and local health departments, and other clinical and public health associates continue to monitor smoking e-cigarette or vaping product use associated lung injury (EVALI). According to the CDC, a total of 2,807 hospitalized EVALI cases or deaths from all 50 states, the District of Columbia, and two US territories (Puerto Rico and US Virgin Islands) have been recorded as of February 2020. Thus, all the factors mentioned above are expected to result in the growth of the acute lung injury market during the forecast period.

Acute Lung Injury Market: Segmental Overview
By therapy, the acute lung injury market is segmented into mechanical ventilation, fluid management, pharmacotherapy, and adjunctive procedures. In 2021, the mechanical ventilation segment is estimated to account for the largest market share in the global acute lung injury market. The segment's growth is attributed to the fact that mechanical ventilation in acute lung injury (ALI) aims to maintain oxygen while avoiding its toxicity and complications associated with the ventilation.

Order a Copy of Acute Lung Injury Market Size, Share, Strategic Insights and Forecasts 2021-2028 Research Report at https://www.theinsightpartners.com/buy/TIPRE00015798/

Based on end user, the acute lung injury market is segmented into hospitals, ambulatory surgery centers, and others. The hospitals segment held the largest share of the market in 2021, and the same segment is anticipated to register the highest CAGR of 4.9% of the market during the forecast period.

Browse Related Reports:
In Vitro Lung Model Market to 2027- Global Analysis and Forecasts by Type (2D, 3D); Application (Drug Screening, Toxicology, 3D Model Development, Physiologic Research, Stem Cell Research, Regenerative Medicine) and Geography

Histopathology Services Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type of Examination (Surgical Specimen, Breast Biopsy, Lung Biopsy, Renal Biopsy, Gastrointestinal Biopsy, Pancreatic Biopsy, Skin Tissue Biopsy, Testicular Biopsy, Others); End User ( Diagnostic Laboratories & Reference Laboratories, Research Institutes, Others ), and Geography

Antibody Drug Conjugates Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Technology (Cleavable Linker, Non-cleavable Linker); Application (Blood Cancer, Brain Cancer, Breast Cancer, Ovarian Cancer, Lung Cancer) and Geography

Neuroendocrine Carcinoma Market Forecast to 2028 - Covid-19 Impact and Global Analysis - by Indication Type (Gastric Neuroendocrine Tumor, Lung Neuroendocrine Tumors, Pancreatic Neuroendocrine Tumors, Appendiceal Neuroendocrine Tumors) ; Treatment Type (Chemotherapy, Antimetabolites, Alkylating agents, Natural Products, Targeted Therapy, Tyrosine Kinase Inhibitor, mTOR Inhibitor, Somatostatin Analogs) ; End User (Hospitals, Clinics, Oncology Centers, Ambulatory Surgical Centers)

Organ Transplant Immunosuppressant Drugs Market Forecast to 2028 - COVID-19 Impact and Global Analysis by THERAPEUTICS (Heart Transplant, Lung Transplant, Kidney Transplant, Liver Transplant); COMMERCIALIZED PRODUCTS (Zenapax, Prograf, Cellcept, Myfortic, Neoral)

Radiation Therapy Market Forecast to 2028 - Covid-19 Impact and Global Analysis - by Product (External Beam Radiotherapy, Internal Beam Radiotherapy/Brachytherapy, and Systemic Radiotherapy), Technology (Image-Guided Radiotherapy (IGRT), Intensity Modulated Radiotherapy (IMRT), Stereotactic Technology, Proton Beam Therapy, 3D Conformal Radiotherapy (3D CRT), Volumetric Modulated Arc Therapy (VMAT), and Others), Application (Prostate Cancer, Breast Cancer, Lung Cancer, Head And Neck Cancer, Colorectal Cancer, and Other Cancers) End user (Hospitals and Independent Radiotherapy Centers) and Geography

Immuno Oncology Assays Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Technology (Immunoassays, PCR, NGS, Flow Cytometry, Others); Indication (Colorectal Cancer, Lung Cancer, Melanoma, Bladder Cancer, Others); Application (Clinical Diagnostics, Research)

Fluorescence Guided Surgery Systems Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (SPY System, PDE System, VS3 Iridium System, Others); Application (Head and Neck Cancer, Breast Cancer, Non-small-cell Lung Cancer, Colorectal Cancer, Bladder Cancer, Prostate Cancer, Others)

Chemotherapy Market Forecast to 2028 - Covid-19 Impact and Global Analysis - by Indication ( Colorectal Cancer, Breast Cancer, Lung Cancer, Stomach Cancer, Ovarian Cancer, Lymphoma, Prostate Cancer, Leukemia, others ); Drug Class ( Topoisomerase Inhibitors, Mitotic inhibitors, Antitumor antibiotic, Alkylating agents, others ); Route of Administration ( Subcutaneous, Intra-Muscular, Intravenous, Intravesicular, Intraventricular/Intrathecal, Topical, Oral, Intraperitoneal, others ); End User ( Hospitals and Clinics, Specialty Centers, others )

PFT Systems Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Complete PFT Systems, Portable PFT Systems); Test Type (Spirometry, Lung Volume, Gas Exchange Testing, Maximal Voluntary Ventilation, Oxygen Titration Test, High Altitude Simulation Testing); Application (Chronic Obstructive Pulmonary Disease (COPD), Asthma, Chronic Shortness of Breath, Restrictive Lung Disease); End User (Hospitals and Clinicals, Diagnostics Laboratories)

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:
If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876
Press Release - https://www.theinsightpartners.com/pr/acute-lung-injury-market

Connect With Us on:
LinkedIn: https://www.linkedin.com/company/7591674/admin/
Twitter: https://twitter.com/tipmarkettrends
Facebook: https://www.facebook.com/theinsightpartners/
YouTube: https://www.youtube.com/c/TheInsightPartners
RSS/Feeds: https://www.theinsightpartners.com/feed/ | https://www.openpr.com/news/archive/139407/The-Insight-Partners.html